首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
【2h】

Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)

机译:一项针对14-18岁儿童的CBT抗精神病药和两者的随机对照试验的研究方案:管理青少年首发精神病:可行性研究(MAPS)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAdolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic medication (APs), cognitive behavioural therapy (CBT) and family intervention (FI). The evidence for APs in treating psychosis is limited in adolescents compared to adults. Nevertheless, it indicates that APs can reduce overall symptoms in adolescents but may cause more severe side effects, including cardiovascular and metabolic effects, than in adults. CBT and FI can improve outcomes in adults, but there are no studies of psychological interventions (PI) in patients under 18 years old. Given this limited evidence base, NICE made a specific research recommendation for determining the clinical and cost effectiveness of APs versus PI versus both treatments for adolescent FEP.
机译:背景:与成人发作性精神病相比,青少年发作性精神病与更严重的症状和更差的预后相关。美国国家临床卓越研究所(NICE)建议应为患有首发性精神病(FEP)的青少年提供抗精神病药物(APs),认知行为疗法(CBT)和家庭干预(FI)的组合。与成年人相比,青少年治疗AP的证据有限。然而,这表明APs可以减轻青少年的总体症状,但可能引起比成年人更严重的副作用,包括心血管和代谢作用。 CBT和FI可以改善成人的预后,但尚无18岁以下患者的心理干预(PI)研究。鉴于这一有限的证据基础,NICE提出了一项具体的研究建议,以确定AP与PI以及两种治疗方式对青少年FEP的临床和成本效益。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号